MARC Record from harvard_bibliographic_metadata

LEADER: 02740pam a22003374a 4500
001 011994061-2
005 20090908183012.0
008 090605s2008 nyua b 001 0 eng
010 $a 2008030344
020 $a9781420068955 (hardcover : alk. paper)
020 $a1420068954 (hardcover : alk. paper)
035 0 $aocn166358474
040 $aDNLM$cDNLM
041 0 $aeng
042 $apcc
050 00 $aRC643$b.C4842 2008
060 00 $a2008 N-256
060 10 $aWH 250$bC556501 2008
245 00 $aChronic lymphocytic leukemia /$cedited by Susan O'Brien, John G. Gribben.
260 $aNew York :$bInforma Healthcare,$cc2008.
300 $axv, 301 p. :$bill. ;$c26 cm.
504 $aIncludes bibliographical references and index.
505 0 $aOrigin and nature of chronic lymphocytic leukemia B cells / Nicholas Chiorazzi and Manlio Ferrarini -- Gene expression profiling in the study of chronic lymphocytic leukemia / Ulf Klein -- Molecular pathogenesis / Arianna Bottoni, Carlo M. Croce, and George A. Calin -- Chronic lymphocytic leukemia and the B-cell receptor / Marta Muzio and Federico Caligaris-Cappio -- Etiology of CLL : the role of MBL / Paolo Ghia and Andrew C. Rawstron -- Apoptosis dysregulation in CLL / Victoria Del Gaizo Moore and Anthony Letai -- Differential diagnosis, staging, and prognostic factors / Thorsten Zenz, Hartmut Döhner, and Stephan Stilgenbauer -- Frontline therapy of chronic lymphocytic leukemia / Barbara Eichhorst and Michael Hallek -- Treatment of patients with relapsed or refractory chronic lymphocytic leukemia / Karen W.L. Yee, Michael J. Keating, and Susan M. O'Brien -- New therapies in chronic lymphocytic leukemia / John C. Byrd ... [et al.] -- Stem cell transplantation in CLL / John G. Gribben -- Gene therapy, vaccines, and immune modulation / William G. Wierda -- Prolymphocytic leukemias / Claire E. Dearden -- CLL-specific complications : autoimmunity and Richter's transformation / Dennis A. Carney and John F. Seymour -- Infectious complications in patients with chronic lymphocytic leukemia / Elias Anaissie.
520 $aUp-to-date picture of CLL and how to better treat patients inflicted with the disease. New information on developments in the molecular pathogenesis of this disease impacts how physicians approach and treat patients with CLL. The various predisposing factors for the disease are addressed along with current and future treatment modalities and recommended standards of care.
650 22 $aLeukemia, Lymphocytic, Chronic, B-Cell$xtherapy.
650 12 $aLeukemia, Lymphocytic, Chronic, B-Cell$xetiology.
650 0 $aChronic lymphocytic leukemia.
700 1 $aO'Brien, Susan,$d1954-
700 1 $aGribben, John.
988 $a20090605
906 $0OCLC